Breast: For women aged 40–49 years, mammography screening every 2 years should be offered if a woman requests it after a discussion of the
potential benefits and harms. For women aged 50–74 years who are in good health, mammography should be encouraged every 2 years.
Cervical: For women aged 21–29 years, cytology testing is recommended
every 3 years. For those aged 30–65, cytology plus HPV testing can be done every 5 years (instead of cytology alone).
Colorectal: For patients aged 50–75 years, one of the following strategies
should be encouraged: high-sensitivity fecal occult blood testing (FOBT)
or fecal immunofluorescence testing (FIT) annually; sigmoidoscopy every 5 years; combined high-sensitivity FOBT or FIT every 3 years plus
sigmoidoscopy every 5 years; or optical colonoscopy every 10 years.
Ovarian: Screening isn't recommended.
Prostate: For men aged 50–69 with a life expectancy of at least a decade,
discuss screening's benefits and risks. If patients prefer screening,
order prostate-specific antigen testing no more than once every 2–4 years.
potential benefits and harms. For women aged 50–74 years who are in good health, mammography should be encouraged every 2 years.
Cervical: For women aged 21–29 years, cytology testing is recommended
every 3 years. For those aged 30–65, cytology plus HPV testing can be done every 5 years (instead of cytology alone).
Colorectal: For patients aged 50–75 years, one of the following strategies
should be encouraged: high-sensitivity fecal occult blood testing (FOBT)
or fecal immunofluorescence testing (FIT) annually; sigmoidoscopy every 5 years; combined high-sensitivity FOBT or FIT every 3 years plus
sigmoidoscopy every 5 years; or optical colonoscopy every 10 years.
Ovarian: Screening isn't recommended.
Prostate: For men aged 50–69 with a life expectancy of at least a decade,
discuss screening's benefits and risks. If patients prefer screening,
order prostate-specific antigen testing no more than once every 2–4 years.